TCL Archive Carbone to Give Up ECOG Chairmanship; DCE’s Adamson Receives Presidential Executive Award October 6, 1989
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors June 7, 2002
